Researchers say they have developed a simple and effective genetic-based test to detect certain gynecological cancers in early stage.
In a breakthrough that offers new hope to the thousands of women who are diagnosed with the diseases each year.
Silent killers such as ovarian and endometrial cancers tend to be so because they are difficult to detect before it might be too late. By the time the diseases are diagnosed, treatment options are often limited.
Because there isn’t any dedicated early-detection tests for ovarian cancer, diagnosis is usually dependent on the appearance of symptoms that are often vague and hard to recognize. In endometrial cancer, doctors also rely on signs such as abnormal vaginal bleeding to make a diagnosis.
This should be a good news to all women as early detection can help prevent further and incurable development cancers.
In a breakthrough that offers new hope to the thousands of women who are diagnosed with the diseases each year.
Silent killers such as ovarian and endometrial cancers tend to be so because they are difficult to detect before it might be too late. By the time the diseases are diagnosed, treatment options are often limited.
Because there isn’t any dedicated early-detection tests for ovarian cancer, diagnosis is usually dependent on the appearance of symptoms that are often vague and hard to recognize. In endometrial cancer, doctors also rely on signs such as abnormal vaginal bleeding to make a diagnosis.
This should be a good news to all women as early detection can help prevent further and incurable development cancers.
0 Comments
Add comment